HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert W Taylor Selected Research

Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia)

1/2020Identification of a novel heterozygous guanosine monophosphate reductase (GMPR) variant in a patient with a late-onset disorder of mitochondrial DNA maintenance.
1/2020Progressive external ophthalmoplegia due to a recurrent de novo m.15990C>T MT-TP (mt-tRNAPro) gene variant.
1/2020Chronic Progressive External Ophthalmoplegia due to a Rare de novo m.12334G>A MT-TL2 Mitochondrial DNA Variant1.
1/2019A novel mitochondrial m.4414T>C MT-TM gene variant causing progressive external ophthalmoplegia and myopathy.
1/2018Topoisomerase 3α Is Required for Decatenation and Segregation of Human mtDNA.
1/2018Disclosing the functional changes of two genetic alterations in a patient with Chronic Progressive External Ophthalmoplegia: Report of the novel mtDNA m.7486G>A variant.
12/2016Peripheral neuropathy in patients with CPEO associated with single and multiple mtDNA deletions.
10/2016Recurrent De Novo Dominant Mutations in SLC25A4 Cause Severe Early-Onset Mitochondrial Disease and Loss of Mitochondrial DNA Copy Number.
6/2015SANDO syndrome in a cohort of 107 patients with CPEO and mitochondrial DNA deletions.
1/2015Clonal expansion of secondary mitochondrial DNA deletions associated with spinocerebellar ataxia type 28.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert W Taylor Research Topics

Disease

105Mitochondrial Diseases (Mitochondrial Disease)
04/2022 - 07/2002
25Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia)
01/2020 - 09/2003
23Muscular Diseases (Myopathy)
05/2022 - 10/2002
16Cytochrome-c Oxidase Deficiency
06/2019 - 06/2006
13Cardiomyopathies (Cardiomyopathy)
04/2022 - 09/2010
13Ataxia (Dyssynergia)
07/2020 - 10/2002
13Mitochondrial Myopathies (Mitochondrial Myopathy)
01/2019 - 10/2002
10Inborn Genetic Diseases (Disease, Hereditary)
01/2020 - 02/2002
10Lactic Acidosis
01/2020 - 10/2002
9Neurodegenerative Diseases (Neurodegenerative Disease)
10/2022 - 03/2006
9Leigh Disease (Leigh's Disease)
01/2020 - 02/2002
9Brain Diseases (Brain Disorder)
01/2020 - 01/2004
8Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
03/2021 - 05/2003
8Neoplasms (Cancer)
12/2020 - 04/2003
8Muscle Hypotonia (Hypotonia)
12/2018 - 09/2012
8Deafness (Deaf Mutism)
01/2017 - 09/2004
7Seizures (Absence Seizure)
01/2019 - 10/2016
6Epilepsy (Aura)
10/2022 - 08/2012
6Ophthalmoplegia (External Ophthalmoplegia)
01/2022 - 07/2005
5MELAS Syndrome (Syndrome, MELAS)
09/2013 - 09/2004
4Stroke (Strokes)
01/2022 - 10/2009
4Atrophy
01/2022 - 01/2012
4Sensorineural Hearing Loss
01/2022 - 10/2002
4Optic Atrophy
01/2021 - 12/2013
4Hearing Loss (Hearing Impairment)
09/2019 - 09/2010
4Liver Failure
01/2019 - 09/2008
4Cataract (Cataracts)
11/2018 - 02/2013
4Kearns-Sayre Syndrome
11/2018 - 08/2004
4Disease Progression
01/2017 - 10/2012
4Fatigue
01/2017 - 08/2012
4Leukoencephalopathies
01/2017 - 07/2012
3Status Epilepticus (Complex Partial Status Epilepticus)
01/2022 - 01/2018
3Nervous System Diseases (Neurological Disorders)
10/2021 - 07/2008
3Carcinogenesis
01/2021 - 10/2019
3Mitochondrial complex I deficiency
01/2020 - 01/2016
3Heart Diseases (Heart Disease)
09/2019 - 05/2003
3Spinocerebellar Ataxias (Spinocerebellar Ataxia)
06/2019 - 01/2015
3Cholestasis
10/2018 - 10/2002
3Respiratory Insufficiency (Respiratory Failure)
01/2018 - 12/2013
3Cerebellar Ataxia (Dysmetria)
01/2018 - 11/2014
3Infections
10/2017 - 09/2006
3Parkinsonian Disorders (Parkinsonism)
01/2016 - 10/2006
3Sepsis (Septicemia)
11/2011 - 04/2004
2Diffuse Cerebral Sclerosis of Schilder (Alpers' Disease)
10/2022 - 01/2019
2Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
09/2022 - 01/2019
2Cataract and cardiomyopathy
04/2022 - 08/2014
2Cardiac Sudden Death (Sudden Cardiac Arrest)
12/2021 - 01/2016
2Dystonia (Limb Dystonia)
07/2021 - 01/2016
2Rhabdomyolysis
01/2020 - 02/2004
2Spastic Ataxia
01/2020 - 05/2014
2Paresis (Hemiparesis)
01/2020 - 01/2014
2Cognitive Dysfunction
01/2020 - 01/2015
2Acute Liver Failure (Fulminant Hepatic Failure)
10/2018 - 12/2016
2Neurologic Manifestations (Neurological Manifestations)
04/2018 - 11/2016
2Hypersensitivity (Allergy)
01/2018 - 07/2011
2Epilepsia Partialis Continua
01/2018 - 01/2018
2Genomic Instability
01/2018 - 01/2016
2Inflammation (Inflammations)
10/2017 - 04/2012
2Drug Resistant Epilepsy
01/2017 - 12/2013
2Liver Diseases (Liver Disease)
12/2016 - 01/2011

Drug/Important Bio-Agent (IBA)

137Mitochondrial DNA (mtDNA)IBA
10/2022 - 02/2002
23Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2006
19Electron Transport Complex IV (Cytochrome c Oxidase)IBA
01/2020 - 02/2004
17EnzymesIBA
01/2022 - 01/2004
16Lactic Acid (Lactate)FDA LinkGeneric
01/2022 - 10/2004
16Transfer RNA (tRNA)IBA
10/2021 - 02/2002
14DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2004
6Mitochondrial Proteins (Mitochondrial Protein)IBA
01/2022 - 09/2014
5Biomarkers (Surrogate Marker)IBA
05/2022 - 11/2016
5Amino AcidsFDA Link
01/2020 - 10/2002
4RNA (Ribonucleic Acid)IBA
01/2022 - 05/2003
4Biological ProductsIBA
01/2022 - 01/2002
4Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA
12/2021 - 10/2002
4coenzyme Q10 (CoQ10)IBA
07/2020 - 02/2012
4NucleotidesIBA
01/2020 - 10/2002
4Lys Transfer RNAIBA
01/2017 - 09/2007
4Ile Transfer RNAIBA
07/2013 - 10/2002
3Ligases (Synthetase)IBA
09/2022 - 01/2015
3MethyltransferasesIBA
01/2022 - 05/2016
3Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
01/2018 - 01/2014
3Glu Transfer RNAIBA
02/2013 - 04/2004
3Ser Transfer RNAIBA
08/2012 - 07/2004
3Phe Transfer RNAIBA
11/2010 - 02/2004
2Inorganic Pyrophosphatase (Pyrophosphatase, Inorganic)IBA
12/2021 - 01/2016
2Ribonuclease P (RNase P)IBA
11/2021 - 05/2016
2TransferasesIBA
10/2021 - 10/2018
2LipidsIBA
07/2020 - 01/2020
2Pro Transfer RNAIBA
01/2020 - 03/2009
2fibroblast growth factor 21IBA
01/2020 - 11/2016
2Mitochondrial RNAIBA
10/2019 - 08/2013
2Alanine-tRNA LigaseIBA
01/2019 - 01/2015
2Inosine TriphosphataseIBA
01/2019 - 03/2013
2Retinaldehyde (Retinal)IBA
11/2018 - 01/2017
2Peptide Hydrolases (Proteases)FDA Link
01/2018 - 01/2015
2DesminIBA
10/2016 - 06/2013

Therapy/Procedure

5Therapeutics
10/2022 - 09/2010
2Cochlear Implants (Cochlear Implant)
12/2017 - 03/2015
2Mechanical Ventilators (Ventilator)
10/2016 - 06/2014
2Drug Therapy (Chemotherapy)
10/2016 - 04/2003
2Length of Stay
01/2016 - 09/2006